Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHARAO: Apnoeic Oxygenation During Nasal Cannula Therapy
NCT03478774Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of oxygen (5 arms), sponsored by Insel Gruppe. Primary endpoint: pCO2 increase. Started Mar 2018; status: completed.
02
Drugs
oxygen
Beyond the preview
Go deeper on NCT03478774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478774.